The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity
53BP1 controls a specialized non-homologous end joining (NHEJ) pathway that is essential for adaptive immunity, yet oncogenic in BRCA1 mutant cancers. Intra-chromosomal DNA double-strand break (DSB) joining events during immunoglobulin class switch recombination (CSR) require 53BP1. However, in BRCA...
Main Authors: | Becker, JR, Cuella-Martin, R, Barazas, M, Liu, R, Oliveira, C, Oliver, AW, Bilham, K, Holt, AB, Blackford, AN, Heierhorst, J, Jonkers, J, Rottenberg, S, Chapman, JR |
---|---|
Format: | Journal article |
Published: |
Springer Nature
2018
|
Similar Items
-
The Transcription Factor ASCIZ and Its Target DYNLL1 Are Essential for the Development and Expansion of MYC-Driven B Cell Lymphoma
by: David M. Wong, et al.
Published: (2016-02-01) -
Dual functions of ASCIZ in the DNA base damage response and pulmonary organogenesis.
by: Sabine Jurado, et al.
Published: (2010-10-01) -
Correction: Dual Functions of ASCIZ in the DNA Base Damage Response and Pulmonary Organogenesis.
by: Sabine Jurado, et al.
Published: (2010-11-01) -
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance
by: Joseph Nacson, et al.
Published: (2018-09-01) -
Telomere-Internal Double-Strand Breaks Are Repaired by Homologous Recombination and PARP1/Lig3-Dependent End-Joining
by: Ylli Doksani, et al.
Published: (2016-11-01)